Bilcare Ltd-$
Bilcare Ltd-$ (BI) last reported results for the quarter ended Jun 2026, with sales of ₹226 crore and net profit of ₹15 crore. The stock last traded at ₹94.8, a market capitalisation of ₹223 crore, on a P/E of 11.2. Over the past 52 weeks the stock has ranged between ₹50 and ₹116. Figures are as of 6 Oct 2026 and are not real time.
Bilcare Ltd-$ share price and key metrics
- Current price
- ₹94.8
- Market cap
- ₹223 cr
- Stock P/E
- 11.2
- Book value
- ₹83.6
- ROE
- 1.39%
- ROCE
- 7.06%
- Dividend yield
- 0.00%
- 52w high / low
- 116/50.0
Metrics as of 6 Oct 2026. Not real time.
Track Bilcare Ltd-$
Cruxal reads every Bilcare Ltd-$ filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Bilcare Ltd-$ growth and returns
- 10 Years
- -12%
- 5 Years
- 3%
- 3 Years
- -9%
- TTM
- -1%
- 10 Years
- -14%
- 5 Years
- 16%
- 3 Years
- 32%
- TTM
- 248%
- 10 Years
- 4%
- 5 Years
- 5%
- 3 Years
- 5%
- 1 Year
- 15%
- 10 Years
- -50%
- 5 Years
- -6%
- 3 Years
- -3%
- Last Year
- 1%
Bilcare Ltd-$ quarterly results
In the quarter ended Jun 2026, sales were ₹226 cr, up 21.5% from ₹186 cr a year earlier. Net profit turned positive at ₹15 cr.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 202 | 198 | 194 | 186 | 178 | 181 | 188 | 226 |
| Expenses | 194 | 187 | 186 | 175 | 175 | 168 | 171 | 189 |
| Operating profit | 8 | 11 | 8 | 11 | 3 | 13 | 17 | 37 |
| OPM % | 3.8% | 5% | 4.0% | 6% | 1.9% | 7% | 9% | 16% |
| Other income | -6 | -6 | 21 | 6 | 4 | 3 | 12 | 0 |
| Interest | 24 | 19 | 19 | 19 | 19 | 17 | 18 | 18 |
| Depreciation | 11 | 12 | 5 | 12 | 12 | 5 | 5 | 4 |
| Profit before tax | -33 | -27 | 6 | -13 | -24 | -6 | 7 | 15 |
| Tax % | -10% | -40% | -119% | -25% | -1% | 3% | -13% | -1% |
| Net profit | -30 | -16 | 12 | -10 | -23 | -6 | 8 | 15 |
| EPS (₹) | -6.81 | -3.04 | 7.47 | -1.61 | -5.25 | 0.41 | 5.68 | 5.39 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Bilcare Ltd-$ annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,633 | 2,778 | 2,997 | 1,827 | 623 | 845 | 982 | 747 | 788 | 734 | 773 |
| Operating profit | 190 | 161 | 170 | 45 | 51 | 60 | 57 | 39 | 46 | 45 | 70 |
| OPM % | 7% | 6% | 6% | 2.5% | 8% | 7% | 6% | 5% | 6% | 6% | 9% |
| Net profit | -80 | -199 | -453 | -99 | -11 | -4 | 50 | -59 | -28 | -17 | -6 |
| EPS (₹) | -35.91 | -85.43 | -193.28 | -43.97 | -8.95 | -5.35 | 6.39 | -14.12 | -0.33 | 0.73 | 6.23 |
TTM is the trailing twelve months to the most recent quarter.
Bilcare Ltd-$ balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 |
| Reserves | 590 | 376 | -93 | 85 | 63 | 52 | 507 | 474 | 191 | 173 |
| Borrowings | 2,014 | 2,089 | 2,270 | 707 | 677 | 690 | 639 | 756 | 689 | 620 |
| Other liabilities | 830 | 913 | 888 | 297 | 300 | 362 | 424 | 314 | 21 | 26 |
| Total liabilities | 3,457 | 3,402 | 3,087 | 1,112 | 1,064 | 1,127 | 1,593 | 1,568 | 924 | 843 |
| Fixed assets | 2,403 | 2,180 | 2,005 | 534 | 494 | 465 | 1,045 | 1,038 | 456 | 432 |
| CWIP | 149 | 170 | 79 | 0 | 0 | 1 | 1 | 1 | 4 | 10 |
| Investments | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 8 | 11 | 14 |
| Other assets | 904 | 1,051 | 1,003 | 577 | 570 | 661 | 545 | 521 | 453 | 387 |
| Total assets | 3,457 | 3,402 | 3,087 | 1,112 | 1,064 | 1,127 | 1,593 | 1,568 | 924 | 843 |
As reported by the company. Total assets equal total liabilities by construction.
Bilcare Ltd-$ cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 300 | 98 | 206 | 256 | 72 | 41 | -7 | 62 | 86 | 128 |
| Cash from investing | -129 | -203 | -104 | 1,309 | 2 | -4 | 36 | -106 | 81 | -5 |
| Cash from financing | -155 | 91 | -103 | -1,600 | -83 | -55 | -19 | 36 | -171 | -132 |
| Net cash flow | 16 | -13 | -1 | -35 | -9 | -18 | 10 | -7 | -3 | -10 |
| Free cash flow | 165 | -115 | 91 | 1,569 | 69 | 37 | 11 | -34 | 142 | 120 |
| CFO / operating profit | 173% | 75% | 148% | 828% | 141% | 78% | -6% | 162% | 192% | 283% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Bilcare Ltd-$ operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 2% | -8% | -6% | -9% | 3% | 3% | 3% | 1% | 4% | 7% |
| Debtor days | 29 | 38 | 38 | 22 | 90 | 95 | 70 | 73 | 55 | 54 |
| Inventory days | 84 | 90 | 82 | 28 | 90 | 83 | 42 | 77 | 80 | 86 |
| Days payable | 81 | 102 | 71 | 35 | 93 | 102 | 77 | 70 | 57 | 70 |
| Cash conversion cycle | 32 | 25 | 49 | 15 | 88 | 76 | 34 | 80 | 78 | 69 |
| Working capital days | -11 | -150 | -156 | -2 | -19 | -10 | -10 | 12 | -5 | 28 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Bilcare Ltd-$ shareholding pattern
Promoters held 30.01% at Jun 2026, broadly unchanged since Jun 2025. FIIs 0.04%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 30.01% | 30.01% | 30.01% | 30.01% | 30.01% | 30.01% | 30.01% | 30.01% |
| FIIs | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% |
| Public | 69.95% | 69.95% | 69.95% | 69.95% | 69.94% | 69.95% | 69.95% | 69.94% |
| No. of shareholders | 18,241 | 18,496 | 17,586 | 17,047 | 16,513 | 16,068 | 15,824 | 15,777 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Cruxal coverage of Bilcare Ltd-$
Bilcare Ltd-$ corporate filings
- Bilcare Limited's AGM results reveal strong shareholder support for key resolutions, with over 64% voting in favor of material related-party transactions, indicating investor confidence in strategic partnerships.AGM/EGMhigh impact
Cruxal's analysis: Bilcare Limited conducted its 39th AGM on 26 September 2026 via video conferencing, with…
Read the full analysis - Intimation of Trading Window Closure for quarter and half year ended 30 September 2026Insider Trading / SASTlow impact
- Bilcare Limited Concludes 39th Annual General Meeting; Approves Key Board Appointments and Related Party TransactionsAGM/EGMlow impact
Cruxal's analysis: Bilcare Limited has successfully concluded its 39th Annual General Meeting held on 26…
Read the full analysis - Bilcare Limited issues corrigendum to 39th AGM notice regarding resolution classificationAGM/EGMlow impact
Cruxal's analysis: Bilcare Limited has issued a formal corrigendum to its 39th Annual General Meeting…
Read the full analysis - Bilcare Limited: Non-promoter group increases stake to 16.47% via open market acquisitionInsider Trading / SASTlow impact
Cruxal's analysis: Bilcare Limited has witnessed an increase in shareholding by a group of non-promoter…
Read the full analysis - Bilcare Limited announces newspaper publication for 2025-26 AGM and Annual Report dispatchCompany Updatelow impact
Cruxal's analysis: Bilcare Limited has fulfilled regulatory requirements under Regulation 30 of the LODR by…
Read the full analysis - Bilcare Limited: Non-promoter shareholders Guttikonda Vara Lakshmi and Guttikonda Rajasekhar reduce stake by 2.64% via open market saleInsider Trading / SASTlow impact
Cruxal's analysis: Bilcare Limited has reported a change in shareholding under SEBI (SAST) Regulations…
Read the full analysis - Bilcare Limited reports turnaround in Q1 FY2027 with consolidated net profit of INR 14.97 croreCompany Updatehigh impact
Cruxal's analysis: Bilcare Limited has reported a significant financial turnaround for the quarter ended 30…
Read the full analysis - Bilcare Limited announces voluntary winding up of a wholly owned subsidiaryCompany Updatelow impact
Cruxal's analysis: Bilcare Limited has formally notified the exchange regarding the voluntary winding up of…
Read the full analysis - Bilcare Limited Reports Q1 FY27 Financial Results, Announces Board Changes and Voluntary Winding Up of US SubsidiaryBoard Meetingmedium impact
Cruxal's analysis: Bilcare Limited reported standalone revenue from operations of 1.94 crore for the quarter…
Read the full analysis - Bilcare Limited schedules Board Meeting for 13 August 2026 to approve June 2026 quarterly financial resultsBoard Meetinglow impact
Cruxal's analysis: Bilcare Limited has formally intimated the Bombay Stock Exchange regarding a Board of…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.